GNR-127
/ Generium
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 05, 2025
A Clinical Trial for Evaluation of Efficacy, Safety and Immunogenicity of GNR-127 (Recombinant ABP Antigen Protein Which Carries a Birch Pollen Allergen [BET V 1] and an Apple Allergen [MAL D 1]) in Patients With Birch Pollen Allergic Rhinitis.
(clinicaltrials.gov)
- P1/2 | N=150 | Active, not recruiting | Sponsor: AO GENERIUM
New P1/2 trial • Allergic Rhinitis • Immunology • Inflammation
1 to 1
Of
1
Go to page
1